-
Je něco špatně v tomto záznamu ?
Epiglottopexy Is a Treatment of Choice for Obstructive Sleep Apnea Caused by a Collapsing Epiglottis
M. Masárová, M. Formánek, O. Jor, V. Novák, A. Vrtková, P. Matoušek, P. Komínek, K. Zeleník
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
MH CZ - 17/DRO - FNOs/2021
Ministry of Health Czech Republic
SGS11/LF/2021
University of Ostrava
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
36143414
DOI
10.3390/life12091378
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Drug-induced sleep endoscopy (DISE) reveals epiglottic collapse to be a frequent cause of obstructive sleep apnea (OSA) and intolerance of positive airway pressure (PAP). These patients require different management. This prospective study aimed to compare transoral laser epiglottopexy outcomes in patients with OSA caused by epiglottic collapse with the patients' previous PAP outcomes. Fifteen consecutive adult patients with OSA and epiglottic collapse during DISE were included; ten were analyzed. Before inclusion, PAP was indicated and ineffective in six patients, one of whom underwent unsuccessful uvulopalatopharyngoplasty. PAP was performed during DISE in all patients before epiglottopexy and was uniformly ineffective. ENT control was performed at 1 week and 1 month, and control limited polygraphy to 6 months after surgery. The apnea-hypopnea index (AHI) and Epworth Sleepiness Scale (ESS) were significantly improved (p < 0.001 and p = 0.003, respectively) in all patients after epiglottopexy. Surgery was successful in 9/10 patients; the remaining patient had a significantly decreased AHI and could finally tolerate PAP. Transoral laser epiglottopexy is used to treat OSA in patients with epiglottic collapse. Unlike other methods, it significantly reduces both AHI and ESS and should be considered for these patients. An active search for OSA patients with epiglottic collapse is recommended to prevent treatment failure.
Department of Pediatric Neurology University Hospital Ostrava 708 52 Ostrava Czech Republic
Faculty of Medicine University of Ostrava 708 52 Ostrava Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22023367
- 003
- CZ-PrNML
- 005
- 20250422075218.0
- 007
- ta
- 008
- 221010s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/life12091378 $2 doi
- 035 __
- $a (PubMed)36143414
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Masárová, Michaela $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 708 52 Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, 708 52 Ostrava, Czech Republic $1 0000000221065490
- 245 10
- $a Epiglottopexy Is a Treatment of Choice for Obstructive Sleep Apnea Caused by a Collapsing Epiglottis / $c M. Masárová, M. Formánek, O. Jor, V. Novák, A. Vrtková, P. Matoušek, P. Komínek, K. Zeleník
- 520 9_
- $a Drug-induced sleep endoscopy (DISE) reveals epiglottic collapse to be a frequent cause of obstructive sleep apnea (OSA) and intolerance of positive airway pressure (PAP). These patients require different management. This prospective study aimed to compare transoral laser epiglottopexy outcomes in patients with OSA caused by epiglottic collapse with the patients' previous PAP outcomes. Fifteen consecutive adult patients with OSA and epiglottic collapse during DISE were included; ten were analyzed. Before inclusion, PAP was indicated and ineffective in six patients, one of whom underwent unsuccessful uvulopalatopharyngoplasty. PAP was performed during DISE in all patients before epiglottopexy and was uniformly ineffective. ENT control was performed at 1 week and 1 month, and control limited polygraphy to 6 months after surgery. The apnea-hypopnea index (AHI) and Epworth Sleepiness Scale (ESS) were significantly improved (p < 0.001 and p = 0.003, respectively) in all patients after epiglottopexy. Surgery was successful in 9/10 patients; the remaining patient had a significantly decreased AHI and could finally tolerate PAP. Transoral laser epiglottopexy is used to treat OSA in patients with epiglottic collapse. Unlike other methods, it significantly reduces both AHI and ESS and should be considered for these patients. An active search for OSA patients with epiglottic collapse is recommended to prevent treatment failure.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Formánek, Martin $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 708 52 Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, 708 52 Ostrava, Czech Republic $1 0000000257592073
- 700 1_
- $a Jor, Ondřej $u Department of Anesthesiology, Resuscitation and Intensive Medicine, University Hospital Ostrava, 708 52 Ostrava, Czech Republic
- 700 1_
- $a Novák, Vilém $u Department of Pediatric Neurology, University Hospital Ostrava, 708 52 Ostrava, Czech Republic
- 700 1_
- $a Vrtková, Adéla $u Department of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, 708 52 Ostrava, Czech Republic $1 0000000205110749
- 700 1_
- $a Matoušek, Petr, $d 1973- $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 708 52 Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, 708 52 Ostrava, Czech Republic $1 0000000209306773 $7 xx0068189
- 700 1_
- $a Komínek, Pavel $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 708 52 Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, 708 52 Ostrava, Czech Republic
- 700 1_
- $a Zeleník, Karol $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 708 52 Ostrava, Czech Republic $u Faculty of Medicine, University of Ostrava, 708 52 Ostrava, Czech Republic $1 0000000313499958
- 773 0_
- $w MED00186366 $t Life $x 2075-1729 $g Roč. 12, č. 9 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36143414 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20221010 $b ABA008
- 991 __
- $a 20250422075220 $b ABA008
- 999 __
- $a ind $b bmc $g 1853836 $s 1174655
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 12 $c 9 $e 20220905 $i 2075-1729 $m Life $n Life (Basel) $x MED00186366
- GRA __
- $a MH CZ - 17/DRO - FNOs/2021 $p Ministry of Health Czech Republic
- GRA __
- $a SGS11/LF/2021 $p University of Ostrava
- LZP __
- $a Pubmed-20221010